IL11 and metabolic dysfunction-associated steatohepatitis: Recently, we documented a previously unappreciated role for interleukin-11 (IL11) in the transformation of HSCs into myofibroblasts in the liver, a defining pathology in non-alcoholic steatohepatitis (NASH) [19].